期刊文献+

阿罗洛尔联合非洛地平治疗慢性肾功能不全合并高血压的随机对照研究 被引量:6

原文传递
导出
摘要 慢性肾功能不全(CRF)合并高血压在临床较为常见,严格控制血压对延缓肾脏疾病进展,保护心、脑等重要脏器,改善预后,提高生活质量都有重要意义。CRF合并高血压使用单个降压药物治疗效果通常不理想,需要联合用药,因此探索疗效佳、不良反应小的降压配伍方案是肾科医师面临的一大课题。阿罗洛尔是一种高血浆蛋白结合率、经肝脏排泄的α、β受体阻滞剂,其降压特点为不影响肾脏血流量,在肾科有着良好的应用前景。
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2009年第2期145-146,共2页 Chinese Journal of Nephrology
  • 相关文献

参考文献3

  • 1倪兆慧,钱家麒,丁小强,梅常林,袁伟杰,汪年松,陈楠,陆福明.盐酸阿罗洛尔治疗慢性肾功能不全合并高血压的多中心研究[J].上海第二医科大学学报,2004,24(12):1038-1041. 被引量:8
  • 2Suzuki H, Moriwaki K, Kanno Y, et al. Comparison of the effects of an ACE inhibitor and alphabeta blocker on the progression of renal failure with left ventricular hypertrophy: preliminary report. Hypertens Res, 2001, 24: 153-158.
  • 3Suzuki H, Nakamoto H, Nemoto H, et al. Control of blood pressure and prevention of end-organ damage in patients with accelerated hypetension by combination with arotinolol and extended release nifedipine. Hypertens Res, 2000, 23 159-166.

二级参考文献14

  • 1土肥和纮 藤本真一 呎井伸之 等.Artinolol对合并肾功能低下的原发性高血压临床疗效[J].新药与临床,1991,40(4):815-827.
  • 2Bakris G. Maximizing cardio-renal benefits: achieve blood pressure goals [ J ]. J Clin Hypertens, 1999,1: 141 - 148.
  • 3Lazarus J, Bourgoignie J, Kuckalew V, et al. For the modification of diet in renal disease study group: archievement and safety of a low blood pressure goal in chronic renal disease: the modification of diet in renal study group [ J]. Hypertension, 1997,29:641 -650.
  • 4Maschio G, Alberti D, Janin G, et al. Effect of the angiotensin convertion enzyme inhibitor benazepril on the progression of chronic renal insufficiency[ J]. N Engl J Med,1996,334: 939-945.
  • 5Ruggenenti P, Perna A, Gherardi G, et al. Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial[ J]. Lancet, 1998,52:1 252 -1 256.
  • 6Ruggenenti P, Perna A, Gherardi G, et al. Effect of the angiotensin convertion enzyme inhibitor on renal prevention in non-nehropaticproteinuric, non-diabetic nephropathy [ J ]. Lancet, 1999,354 : 359- 364.
  • 7Ihle BU, Whitworth JA, Shainfar S, et al. Angiotensin converting enzyme inhibition in nondiabetic progressive renal insufficiency: a controlled double blind trial[J]. Am J Kidney Dis, 1996,27:489- 495.
  • 8Nissenson AR, Collins AJ, Hurley J, et al. Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns[J]. J Am Soc Nephrol, 2001,12 (8): 1 713-1 720.
  • 9Cinotti GA, Zucchelli PC. Collaborative Study Group. Effect of Lisinopril on the progression of renal insufficiency in mild proteinuric non-diabetic nephropathies[ J]. Nephrol Dial Transplant, 2001, 16(5): 961 -966.
  • 10Miyagishi A, Nakahara H, Hara Y. Adrenoceptor blocking effects of artinolol, a new combined alpha-and beta-adrenoceptor blocker agent[J]. Arch Int Pharmacodyn Ther,1984,27:248 -264.

共引文献7

同被引文献139

引证文献6

二级引证文献386

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部